MedTrace Logo

Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain

NCT02729207 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2021-10-19

No results posted yet for this study

Summary

The safety and the efficacy of the Esflurbiprofen Hydrogel Patch will be assessed in comparing with placebo in the treatment of acute pain due to ankle sprain

Conditions

  • Ankle Sprain

Interventions

DRUG

Esflurbiprofen Hydrogel Patch

One patch per day for 7 days

Sponsors & Collaborators

  • Teikoku Seiyaku Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Masaru Kaneko, MD · SNBL Clinical Pharmacology Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2016-12-21
Completion
2016-12-27

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02729207 on ClinicalTrials.gov